Toll-like receptor agonist

This page covers all Toll-like receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting TLR7, TLR8, TLR7/TLR8.

Targets

TLR7, TLR8 · TLR7/TLR8

Marketed (1)

• Zyclara® · Actavis Inc. · Dermatology/Oncology
  Zyclara is an imiquimod cream that activates toll-like receptors (TLR7 and TLR8) on immune cells to stimulate local and systemic immune responses against skin lesions.

Phase 3 pipeline (1)

• Imiquimod Vehicle · Apotex Inc. · Dermatology/Immunology
  Imiquimod vehicle is a topical formulation base designed to deliver imiquimod, a toll-like receptor 7/8 agonist that activates innate immune responses.